Submit a Policy Issue NOW to Be Shared at the 2023 NDMA Annual Meeting
How to Submit a Policy Issue
To introduce a policy issue, NDMA members are invited to submit policy issues by completing a Policy Form here and submitting it to NDMA.
If you prefer to use a fillable form, download this option here.
The deadline to submit a policy issue is Friday, September 15th by 5:00 pm (CT). If you need assistance contact NDMA at 701-223-9475.
The following are submitted policies that will be shared and vetted at the Annual Meeting Policy Forum.
If you have a concern not covered on this list, please submit your policy idea by September 15.
Regulatory Oversight of the Use of Artificial Intelligence for Prior Authorization and Patient Claims
To manage the increasing number of prior authorization requests and payment claims, insurers turn to artificial intelligence (AI) to speed up requests. The use of artificial intelligence can interrupt care, divert resources from patients and complicate medical decision-making.
Physicians' Medical History and Credentialing
Organizations involved in credentialing should only require disclosure of physical or mental health condition when a physician is suffering from any condition that impairs judgment or ability to practice medicine.
Research indicates that a great clinician resignation lies ahead and predicts a more widespread clinician exodus.
This invisible gas is the second leading cause of lung cancer and North Dakota is among the highest-risk states for radon exposure. More education is needed to make homeowners, home buyers and sellers aware of the dangers.
Medicare Payment Reform
Medicare physician payment effectively declined 26% from 2001 to 2023, even before additional inflation. Congress needs to turn its attention to fixing Medicare so we can preserve access for patients.
Plans of Family Care
Pregnant, postpartum, and parenting individuals with an opioid use disorder (OUD) or other substance use disorder (SUD) should be encouraged to enter treatment and not suffer punitive actions for starting or continuing treatment, including when medications for opioid use disorder (MOUD) are part of the treatment protocol.
If you'd like to review policy concepts - or just need some feedback prior to submitting, CONTACT NDMA EXECUTIVE DIRECTOR COURTNEY KOEBELE: 701-223-9475 or reach out by email at email@example.com